Interview: Laurent-Dominique Piveteau – CEO, Debiotech, Switzerland

09.01.2018
Laurent-Dominique Piveteau, CEO of Swiss medtech innovator Debiotech, discusses digital disruption, Swiss innovation, and future growth drivers. As well as being CEO of Debiotech, you also lecture courses at EPFL on “Economics of Innovation in the Biomedical Industry”. What are your thoughts on the incorporation of disruptive technologies in the medical world? Is the life sciences sector really ten years late to the party?
"The central part of the spirit of Debiotech is to have an impact, and not just gain financial revenues."
Become a PharmaBoardroom Member for free to access this content
Join the 20,000+ pharmaceutical professionals who already subscribe to PharmaBoardroom
Register
Already a member? Sign In
Tags:
Switzerland, Debiotech, Medtech, Innovation, R&D

Related Interviews

Bruno Delie – General Manager, Luye Pharma Switzerland

Luye Pharma is a China-headquartered fully integrated oncology and CNS specialist. Bruno Delie, general manager for Switzerland, discusses the organization’s ambitious European expansion plan, looking to establish affiliates in the…

Karin Blumer – Director Global Patient Engagement, Novartis Oncology

Karin Blumer, director of global patient engagement at Swiss giant Novartis, gives fascinating insights into the global patient advocacy landscape today and how Novartis interacts with it, the work being…

Barbara Fritsche-Surchat – Managing Director, Servier Switzerland

Barbara Fritsche-Surchat outlines Servier’s historic commitment to Switzerland, how the French mid-cap’s global oncology pivot is translating into its Swiss operations, and comments on the evolution of pharma salesforces post-pandemic.…

Related Articles

Global / Roche to Disentangle from Novartis, Ending Two Decades of Constraints

After 20 years, Novartis will no longer own one third of Roche’s shares after the two Swiss pharma giants agreed to a transaction worth USD 20.7 billion. While Roche touted…

Long Read / Swiss Biotech - Onwards & Upwards

This piece forms part of InFocus Biotechs to Watch Switzerland 2021, a deep dive into the Swiss biotech ecosystem and fundamentals, featuring data sets, feature articles, and profiles of some…

Europe / Top 5 Countries for Pharma Production

The Top Five countries in Europe for pharma production. All located in Western Europe, Switzerland punches well above its weight to take top spot. This data is taken from the 2021…

Latest Report

Singapore Pharma Report 2021

Related Content

Switzerland
Debiotech
Medtech
Innovation
R&D